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Summary. Transmembrane s gment proteases comprise a novel 
class of proteases that cleave substrates within hydrophobic 
membrane-spanning se ments. They cleave in parts of proteins that 
upon first glance should be protected by the hydrophobic environ- 
ment of the lipid bilayer. At present, no such protease has been iso- 
lated and biochemically characterized. They are defined according 
to the appearance of the respective cleavage products. All trans- 
membrane segment proteases eem to participate in a regulated 
two-step roteolytic process that plays a central role in cellular eg- 
ulation or is part of a protein degradation pathway. 
Keywords: Endoplasmic reticulum; Signal peptide peptidase; 
7-Secretase; SREBR 
Abbreviations: 13-APP 13-amyloid precursor protein; S1P site-1 
protease; S2P site-2 protease; SPase signal peptidase; SPPase signal 
peptide peptidase; SREBP sterol regulatory element-binding 
protein; SCAP SREBP cleavage-activating protein. 
degradation i  addition to the proteasome (Jensen 
et al. 1995, Moriyama et al. 1998). Particular interest in 
transmembrane segment proteases arose from findings 
showing that some of these proteases generate prod- 
ucts that regulate cell functions. 
This review will emphasize the common principles 
of the new type of proteases and focus on the three 
transmembrane s gment proteases that seem to be 
localized in the ER of mammalian cells. These pro- 
teases are (i) site-2 protease that activates terol reg- 
ulatory element-binding proteins, (ii) 7-secretase that 
is involved in the generation ofamyloidogenic peptide 
AI3, and (iii) signal peptide peptidase that releases 
signal peptide fragments. 
Introduction 
Proteases are found in almost every organelle of 
eukaryotic cells. They play constructive roles by 
proteolytic processing of precursor proteins or act in 
degradative processes. Wherever proteases hydrolyse 
peptide bonds, cleavage occurs in an aqueous com- 
partment because the hydrophobic environment ofthe 
lipid bilayer precludes hydrolysis. Nevertheless, it has 
become clear that various organelles contain a new 
class of proteases that cleave substrate proteins within 
membrane-spanning se ments. Such transmembrane 
segment proteases can be involved in the degradation 
of membrane proteins like the mAAA protease in the 
mitochondrial inner membrane (Leonhard et al. 1996) 
and may contribute to endoplasmic-reticulum (ER) 
* Correspondence and reprints: Institut fiir Biochemie II, ETH- 
Zentrum, Universit~itstrasse 16, CH-8092 Ztirich Switzerland. 
Common features 
All transmembrane s gment proteases known at 
present act in a characteristic two-step proteolytic 
process. In a first step, the substrate protein is cleaved 
within its hydrophilic ectodomain. The residual 
membrane-bound fragment is next cleaved within the 
transmembrane s gment and the resulting products 
are released into the cytosol or the exoplasmic space 
(Lyko et al. 1995, Bunnell et al. 1998, Duncan et al. 
1998). The two-step rocess usually involves auxiliary 
factors that may activate the proteolytic ascade, reg- 
ulate the proteases, or deliver the substrate. 
According to the cleavage sites, transmembrane 
segment proteases can be devided in two groups 
(Table 1). Group 1 transmembrane segment proteases 
cleave close to the cytoplasmic end of membrane- 
spanning segments, in the region of the hydrophilic 
phospholipid head groups. Group 2 proteases cleave 
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Protease Sequence of membrane-spanning se ment and cleavage sites Substrate protein Intracellular localization 
Group 1 (cleavage close to the cytosolic surface of the membrane) 
S2P .. .  DRSRILLCVLTFLCLSFNPLTSLLQWGGAH... 
nn b .. .  QLHLMYVAAAAFVLLFFVGCGVLLSRKR.. .  
Group 2 (cleavage in the centre of the transmembrane region) 
y-Secretase c . . .  SNKGAI IGLMVGGWlATVIVITLVMLKKK. . .  
SPPase a ...  KGSRLLLLLVVSNLLLCQG... 
mAAA protease e . . .  HDNIMYYLVVILFVGWILLSIIR_N_Y... 
SREBP-2 
mNotch-1 
13-APP 
signal sequence 
(bovine 
preprolactin) 
COXII-DHFR 
endoplasmic reticulum (?) 
plasma membrane (?) 
endoplasmic reticulum (?), 
endosomes (?) 
endoplasmic reticulum 
mitochondrial inner membrane 
" In boldface, cleavage sites in the hydrophobic transmembrane segment; solid underline, exoplasmic side; broken underline, cytosolic side 
b Notch proteins are ligand-activated transmembrane receptors in the plasma membrane. Cleavage by an unidentified protease in the trans- 
membrane segment enables the released fragment to enter the nucleus (Schroeter et al. 1998) 
c 7-Secretase(s) can cleave the transmembrane segment of J3-APP at alternative sites, predominantly atthe indicated positions, generating 
A[340 (at I) or A~42 (at T) 
d SPPase cleaves the preprolactin signal peptide within the region of the small residues in the centre of the transmembrane s gment. 
The exact cleavage site is not known (Lyko et al. 1995) 
e mAAA protease is part of a proteolytic system for the ATP-dependent degradation of inner membrane proteins in mitochondria 
Leonhard et al. 1996). COX II-DHFR, hybrid protein of cytochrome oxidase subunit II (1-74) and dihydrofolate reductase 
an the centre of transmembrane s gments. Actually, it 
is not known so far whether cleavage of a transmem- 
brane segment occurs within the lipid bilayer. It is con- 
ceivable that the active site of group 1 proteases is 
placed within a groove that faces the cytosolic side of 
the membrane and is accessible to water for hydroly- 
sis. Cleavage by group 2 proteases may require a more 
complex mechanism. Transfer of the substrate protein 
to either side of the membrane prior to cleavage seems 
unlikely since fragments can be released to both sides 
of the membrane. These proteases may be part of a 
multisubunit membrane protein complex similar to 
mitochondrial mAAA protease and provide water 
through the inside of the complex to the active site. 
Site-2 protease: activation of  a transcription factor 
The best characterized transmembrane s gment pro- 
tease at present is site-2 protease (S2P) that cleaves 
sterol regulatory element-binding proteins (SREBPs) 
within one of their two membrane-spanning se ments 
(Rawson et al. 1997). SREBPs are membrane-bound 
transcription factors that regulate the expression of 
proteins involved in synthesis and uptake of choles- 
terol and fatty acids in mammalian cells (Brown and 
Goldstein 1997). They share a common structure 
comprising three domains: (i) a cytosolic N-terminal 
domain containing a basic helix-loop-helix leucin 
zipper element and an acidic transcriptional ctivation 
sequence, (ii) a central segment with two membrane- 
spanning helices separated by a hydrophilic loop that 
is exposed toward the ER lumen, and (iii) a C- 
terminal regulatory domain that is exposed into the 
cytosol. SREBPs are anchored in the ER membrane 
and nuclear envelope and are released from the mem- 
brane in a two-step roteolytic process. 
Processing of SREBPs is initiated by a protease, 
termed S1R when sterols are depleted in a cell (Sakai 
et al. 1996). S1P cleaves SREBPs in the lumenal oop 
and generates two fragments, each anchored with a 
single membrane-spanning segment (Fig. 1 a) (Sakai 
et al. 1998). Next, a second protease, S2R cleaves the 
N-terminal intermediate at a leucine-cysteine bond 
that is located within the membrane-spanning se ment 
(Duncan et al. 1998). This liberates the transcription 
factor domain that is released into the cytosol, enters 
the nucleus, and activates gene transcription. 
Cleavage by S1P involves the regulatory protein 
SCAP (for SREBP cleavage-activating protein). This 
putative sterol sensor is a polytopic membrane protein 
that is localized in the ER membrane (Nohturfft et al. 
1998). It consists of two domains: (i) an N-terminal 
domain with several membrane-spanning segments 
containing a putative sterol-sensing subdomain and 
(ii) a C-terminal cytosolic domain containing several 
WD repeats that bind to the regulatory domain of 
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SIP and S2P have both been identified recently by 
complementation cloning. According to the deduced 
amino acid sequence, S1P is a C-terminally anchored 
type I membrane protein. Its large exoplasmic domain 
contains a catalytic triade that is typical for the subtil- 
isin family of serine proteases (Sakai et al. 1996). Sen- 
sitivity toward endoglycosidase H suggests that SIP is 
N-glycosylated and localized in the ER. The analysis 
of the amino acid sequence of S2P revealed aHEXXH 
consensus sequence that is found in many families of 
metalloproteases (Rawson et al. 1997). Unlike any 
other known metalloprotease, S2P shows extensive 
hydrophobicity. It has up to five putative transmem- 
brane segments, one of which containing the metallo- 
protease consensus sequence. The transmembrane 
segments may assemble to a substrate-binding groove 
that places the catalytic site into the membrane. 
Fig. la-c. Transmembrane segment cleavage is part of a two-step 
process, a Processing ofSREBR S1P cleaves SREBP in the lumenal 
loop between the regulatory domain (Reg) and the transcription 
factor domain (TF). S2P next cleaves the N-terminal membrane- 
anchored intermediate within the membrane-spanning segment and 
liberates the transcription factor domain, b Proteolytic processing of 
13-APE a- or [~-secretase cl aves [~-APP in its exoplasmic domain. 
The membrane-anchored fragment is next cleaved by 7-secretase 
within the transmembrane segment and peptide p3 or A[3 is released 
from the membrane, c Cleavage and processing of signal sequences. 
After membrane insertion, the signal sequence of a nascent 
polypeptide chain is cleaved off by SPase and further processed by 
SPPase. The N-terminal signal peptide fragment is released into the 
cytosol. Hydrophobic membrane-spanning segments are indicated 
in yellow 
SREBPs. In sterol-depleted cells, SCAP and SREBP 
form a tight complex that recruits S1P and initiates the 
proteolytic processing of the bound SREBP (Sakai 
et al. 1997). The function of SCAP may be to deliver 
the substrate to S1P or vice versa and thereby to 
prevent the protease from unspecifically degrading 
other proteins in the ER lumen. 
T-Secretase: generation of amyloidogenic peptides 
[3-Amyloid precursor proteins (~-APPs) were the first 
proteins discovered that are processed within a 
transmembrane s gment (Selkoe 1998). 13-APPs are 
ubiquitously expressed type I membrane proteins with 
unknown function. During trafficking along the secre- 
tory pathway, they undergo endoproteolytic cleavages 
that yield amyloidogenic peptide A[3 and other prod- 
ucts that are secreted. A~ is the major constituent 
of amyloid plaques in the brain of patients with 
Alzheimer's disease (Iwatsubo et al. 1994). 
Several proteolytic steps in ~3-APP processing have 
been described (Shoji et al. 1992). First, unidentified 
c~- and 13-secretase(s) cleave ~3-APP in its exoplasmic 
domain generating the C-terminally anchored frag- 
ments p3CT and A4CT, respectively (Fig. 1 b). Both 
are then cleaved by unknown y-secretase(s) within 
their transmembrane s gment yielding nonamyloido- 
genic peptide p3 and amyloidogenic Af3. Cleavage of 
A4CT occurs after residue 40, generating A~40, occa- 
sionally after residue 42, generating A~42. Increased 
levels of A~342 might be sufficient to cause Alzheimer's 
disease. 
Since c~, [3-, and y-secretases are not identified, their 
putative subcellular localization is derived from the 
appearance of the respective cleavage products. A 
portion of A~40 seems to be generated in early endo- 
somes following internalization of [3-APP from the 
plasma membrane (Koo and Squazzo 1994). A~40 and 
A1342 can also be produced early in the secretory 
pathway. In neurons, for example, A~42 is generated in
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the ER whereas A~40 is made in the trans-Golgi 
network (Hartmann et al. 1997, Lee et al. 1998). These 
observations uggest that pairs of secretases are 
present in several organelles. Secretases may be part 
of the protein degradation machineries in endosomes 
and the ER. Misfolded [3-APE for example, may fail 
the quality control in the ER and become degraded 
(Bunnell et al. 1998, Yang et al. 1998). After cleavages 
in the lumenal domain and the transmembrane 
segment, a portion of A[3 peptides may escape further 
degradation and may be secreted. 
Generation of A[342 in the ER is influenced by 
polytopic membrane proteins termed presenilins (De 
Strooper et al. 1997). Mutations in the genes encoding 
presenilin 1and 2 account for the majority of cases of 
Alzheimer's disease (Haass 1996). Presenilins interact 
with a minor portion of [3-APP molecules, preferen- 
tially with the immature N-glycosylated [3-APP but not 
with the (N+O)-glycosylated protein (Weidemann 
etal. 1997). They may aid in maturation and/or 
trafficking of ~-APR Mutations in presenilin which 
cause Alzheimer's disease may induce conformational 
changes that disturb proper interaction with [3-APP 
and favour fragmentation to A[342. Production of A[342 
in the ER may thus be the result of a failed quality 
control, raising the hypothesis that ER-resident ~- and 
y-secretases may perform initial steps in the degrada- 
tion of aberrant membrane proteins. 
Signal peptide peptidase: release of functional 
peptides 
Signal peptide peptidase (SPPase) has been defined as 
a proteolytic activity in the ER membrane according 
to the observation that signal peptides derived from 
secretory and membrane proteins are cleaved within 
the transmembrane segment (Lyko et al. 1995). Find- 
ings that signal peptide fragments can perform 
regulatory and other functions in a cell raised the 
hypothesis that SPPase may play a central role in 
cellular regulation similar to S2P (Martoglio and 
Dobberstein 1998). 
Signal sequences are essential for targeting secre- 
tory proteins and many membrane proteins to the ER 
membrane and mediate the entry into the secretory 
pathway (Walter and Johnson 1994). For translocation 
across the ER membrane, nascent polypeptides enter 
the protein-conducting channels in a looplike confor- 
mation with the N terminus of the signal sequence 
remaining in the cytosol and the C-terminal portion 
being translocated (Rapoport et al. 1996). During 
translocation, signal sequences are usually cleaved off 
from the precursor protein by signal peptidase (SPase) 
(Fig. 1 c). Cleavage occurs close to the lumenal side of 
the ER membrane (Dalbey et al. 1997). Liberated 
signal peptides enter the lipid bilayer and are next 
cleaved within the hydrophobic membrane-spanning 
segment by SPPase (Lyko et al. 1995, Martoglio et al. 
1997). The resulting N- and C-terminal fragments are 
released into the cytosol and ER lumen, respectively. 
Cleavage by SPPase is sensitive to the immuno- 
suppressive drug cyclosporin A (Klappa et al. 1996). 
Cyclosporin A usually binds to cellular proteins 
termed cyclophilins that have proline isomerase activ- 
ity and are thought o assist protein folding and to 
modulate the activity of various enzymes (Schreiber 
and Crabtree 1992). It is therefore conceivable that a 
cyclophilin in the ER regulates the activity of SPPase. 
While SPase is biochemically characterized, SPPase 
is not identified. The mammalian SPase has been 
purified as a complex of five subunits with molecular 
masses of 12, 18, 21, 22/23, and 25 kDa (Evans and 
Blobel 1986). The 18 and 21 kDa subunits are homo- 
logues of the Escherichia coli leader peptidase that 
performs ignal sequence cleavage as a single protein. 
The crystal structure of the latter protein has recently 
been resolved (Paetzel et al. 1998). The membrane- 
anchored serine protease contains an exoplasmic 
domain with the active site close to the membrane. 
It is thus likely that also the 18 and 21 kDa subunits 
of the mammalian SPase cleave the signal sequence 
from the precursor protein. The function of the other 
SPase subunits is not clear. Further studies will 
show whether one of them catalyses cleavage of 
the liberated signal peptide within the transmembrane 
segment or whether other proteins perform this 
step. 
What could be the role of an SPPase? One function 
could be to catalyse the first step of signal peptide 
degradation. It has been shown that synthetic signal 
peptides enter lipid bilayers and can lyse biological 
membranes (Hoyt and Girasch 1991, Killian et al. 
1990). A mechanism is therefore required to efficiently 
remove signal peptides from the ER membrane 
because otherwise their accumulation would severely 
affect the permeation barrier. Cleavage of liberated 
signal peptides within the transmembrane s gment 
would facilitate their release from the membrane. 
A motif for cleavage by SPPase may rely in the helix- 
break-helix structure that is present in the hydro- 
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phobic transmembrane s gment of signal sequences 
but usually not in membrane-spanning segments of 
membrane proteins (van Klompenburg and de Kruijff 
1998). 
Recent studies revealed that peptides derived from 
signal sequences have a role in the regulation of 
cellular functions including virus-host interactions 
(Martoglio and Dobberstein 1998). In a cell-free 
system using ER-derived microsomes it has been 
shown that N-terminal signal peptide fragments of the 
hormone preprolactin and the HIV-1 envelope pro- 
tein gpl60 are released into the cytosol where they 
efficiently bind to calmodulin in a calcium-dependent 
manner (Martoglio et al. 1997). Both signal sequences 
have properties in their N-terminal extensions that 
favour binding to calmodulin. Studies in living B cells 
have revealed a specific association of signal peptide 
fragments derived from HLA-A,  -B, and -C MHC class 
I molecules with HLA-E  MHC class I molecules 
(Braud et al. 1998). The HLA-E molecules present he 
signal peptide fragment at the cell surface to inhibitory 
receptors of natural killer cells. It is thought hat the 
killer cells thereby gauge indirectly via the presented 
signal sequence fragments the overall level of HLA 
class I molecules expressed on B cells which is an 
indicator of the health status of the cell (Long 1998). 
These findings suggest hat the presumably regulated 
production of signal peptide fragment by SPPase 
contributes to cellular regulation. 
Concluding remarks 
Proteases can generate hormonelike signals via a 
number of mechanisms. Cleavage of transmembrane 
segments is a unique way in which proteases can 
liberate active peptides and modulate cell functions. 
The two-step roteolytic process that includes a trans- 
membrane segment protease seems to be regulated as 
it is the case for almost all biological systems requir- 
ing a series of proteolytic steps. Many questions 
remain open. What are the sequences and physical 
properties of transmembrane s gment proteases? Do 
several types of these proteases exist in the ER and 
elsewhere in the cell? What is the mechanism by which 
the proteases cleave transmembrane segments? 
Knowledge about transmembrane s gment proteases 
and the cellular processes they are involved may 
provide novel targets for therapeutics in treating 
Alzheimer's disease, cholesterol-induced coronary 
heart disease, and virus infections. 
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